Harlan Krumholz

Dr. Harlan Krumholz, a leading research scientist at Yale and co-lead of the Paxlovid Trial, discusses the Listen Study and Paxlovid Trial, highlighting the challenges faced by long COVID patients in healthcare. The conversation also delves into the potential of Paxlovid in treating COVID, the patient-centric approach of research studies, and the importance of involving patients in research despite conflicts and challenges.

Prof. Harlan Krumholz, cardiologist at Yale University, discusses his latest studies on Long Covid, including the LISTEN study, Paxlovid trial, and research into internal tremors and vibrations. He advocates for patient-centric care and emphasizes the importance of collaboration and advocacy for Long Covid patients. The chapter also explores challenges faced by patients, the need for open science and public comment on research, and the impact of internal tremors on individuals with Long Covid.